Umbrella Labs Tesamorelin Peptide Research Use Only Program Advances High Rigor GHRH Receptor Signaling, GH Axis Modeling, And Endocrine Systems Bench Science

February 19, 2026 2:00 AM

Umbrella Labs today announced expanded research procurement availability of tesamorelin in lyophilized vial format to support laboratories building reproducible, documentation forward studies in GHRH receptor signaling and growth hormone axis modeling. The program is designed for assay developers and research teams that require traceable sourcing, stable specifications, and consistent handling expectations across multi run experimental...

Read more

TRNR Signs Definitive Agreement to Acquire Ergatta, Increasing 2026 Pro Forma Revenue Guidance by 50% to More than $30m

February 18, 2026 11:30 AM

AUSTIN, TX and BROOKLYN, NY / ACCESS Newswire / February 18, 2026 / Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or the "Company"), owner of the Wattbike, FORME, and CLMBR connected fitness brands, today announced it has signed a definitive agreement to acquire Ergatta, Inc., the pioneer in game-based connected fitness. The parties signed a letter of intent on January 9, 2026, and have been working on the binding definitive agreement since...

Read more

CVS Health Announces $5 Million Scholarship Program To Support Future Pharmacists in Louisiana

February 18, 2026 10:20 AM

Originally published on CVS Health Company NewsCVS Health® (NYSE:CVS) today announced the launch of a new $5 million scholarship program designed to support aspiring pharmacists in the state of Louisiana. The initiative will provide financial assistance to students pursuing their Doctor of Pharmacy (PharmD) degree at either Xavier University of Louisiana or the University of Louisiana at Monroe.This initiative is part of CVS Health's broader...

Read more

Fortified Health Security Debuts Scalable TPRM Solution for Healthcare

February 18, 2026 10:00 AM

Fortified Health Security, five-time consecutive Best in KLAS winner and healthcare's cybersecurity partner, now offers clients a next-gen TPRM solution.TPRM now with VendorIQ is designed to help healthcare organizations manage third-party vendor risk in a way that drives real risk reduction at scale with greater speed, efficiency, and clarity.By embedding healthcare cybersecurity experts directly into procurement workflows and individually...

Read more

Ankle Injuries Among the Most Common Sports Injuries as Baseball Season Kicks Off

February 18, 2026 9:23 AM

Ankle & Foot Centers of America is encouraging patients not to ignore ankle pain this February. Whether caused by a sports injury, a fall, or everyday missteps, ankle injuries can lead to long-term complications if left untreated.As winter activities, travel, and new fitness routines increase at the start of the year, podiatrists are seeing a rise in ankle sprains, strains, and fractures. Seeking professional evaluation early can help reduce the...

Read more

Tivic and BARDA Continue Discussions of Entolimod for Acute Radiation Syndrome on March 10

February 18, 2026 9:15 AM

Tivic (Nasdaq:TIVC), a late-stage immuno-therapeutics company, today announced that a second, follow-up meeting with the Biomedical Advanced Research and Development Authority (BARDA) has been scheduled for March 10, 2026, to continue discussions focused on clinical data and the potential for funding and, ultimately, stockpiling Entolimod™ for Acute Radiation Syndrome (ARS).On January 26, 2026, Tivic attended an initial TechWatch meeting with...

Read more

Jaguar Health Announces a Special One-time Stock Dividend

February 18, 2026 9:00 AM

Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or "the Company") today announced that its Board of Directors has declared a one-time special stock dividend (the "Special Stock Dividend") to holders of Jaguar Common Stock and certain outstanding warrants as of record on March 2, 2026. The Special Stock Dividend will consist of the Company's Series O Convertible Preferred Stock (the "Preferred Stock").Only persons who own shares of the Company's...

Read more

FDA Grants PMA Approval to LimiFlex(TM) Dynamic Sagittal Tether

February 18, 2026 9:00 AM

The U.S. Food and Drug Administration (FDA) has granted Premarket Approval (PMA) to the LimiFlex™ Dynamic Sagittal Tether, a motion-preserving system for the treatment of lumbar spinal stenosis associated with Grade I degenerative spondylolisthesis following decompression. Developed by Empirical Spine (San Carlos, CA) from foundational research at Stanford University, LimiFlex represents more than twenty years of refinement and clinical...

Read more

EDGE Surgical Announces $125,000 Distribution Agreement with Specialty Med-Surg Device

February 18, 2026 9:00 AM

EDGE Surgical, Inc., the innovative brand behind the world's only electronic depth gauge for orthopedic surgery, has announced a $125,000 agreement with Specialty Med-Surg Device to serve as an authorized distributor for the Ortho EDG® Universal Electronic Depth Gauge in the Detroit metro area.This relationship arrives at a critical time, driven by the growing demand for the Ortho EDG®. Med-Surg Device will distribute EDGE Surgical's innovative...

Read more

Tenon(R) Medical Strengthens Intellectual Property Portfolio with Strategic Patent Expansion

February 18, 2026 8:35 AM

Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company redefining care for patients suffering from sacro-pelvic disorders, today announced a strategic expansion of its U.S. intellectual property portfolio following receipt of Notices of Allowance from the United States Patent and Trademark Office (USPTO) for multiple patent applications expected to issue in 2026. These newly allowed claims will further strengthen the Company's...

Read more

Wellgistics Health Targets Expansion into $6.3 Billion Mental Health Software Market with Strategic Investment into Stealth Mental Health AI Startup

February 18, 2026 7:40 AM

Wellgistics Health, Inc. (NASDAQ:WGRX), a health information technology leader, integrating proprietary pharmacy dispensing optimization artificial intelligence (‘AI') platform EinsteinRx™ into its patented blockchain-enabled smart contracts platform PharmacyChain™, today announced that it has completed a strategic investment in a San Francisco-based mental health AI startup on the cusp of launching its service following successful beta testing....

Read more

AQP ONE Launches JBA AICare(TM), Introducing a Physiological Intelligence System into the $100+ Billion Global Wearable Market

February 18, 2026 7:00 AM

AQP ONE Inc., a U.S.-based health technology company founded by Vietnamese refugee entrepreneur, engineer, and University of Minnesota-trained chemist Tracy (Trang) Nguyen, today announced the launch of JBA AICare™, a physiological intelligence system designed to help individuals understand their health earlier and more continuously.The global wearable technology market is projected to exceed $100 billion in the coming years, fueled by advances...

Read more

Moderna Announces the U.S. Food and Drug Administration will Initiate the Review of Its Investigational Seasonal Influenza Vaccine Submission

February 18, 2026 7:00 AM

Moderna, Inc. (NASDAQ:MRNA) today announced that, in response to a prior Refusal-to-File (RTF) letter, the Company engaged with the U.S. Food and Drug Administration (FDA) in a Type A meeting and proposed a revised regulatory approach for its investigational seasonal influenza vaccine candidate, mRNA-1010. To advance the review, Moderna proposed a regulatory pathway based on age, seeking full approval for adults 50 to 64 years of age and...

Read more

Senzime Secures Credit Line Facility of 50 MSEK

February 18, 2026 2:50 AM

Senzime AB (publ.) (STO:SEZI)(OTCQX:SNZZF) announces that the company has secured a credit line facility of 50 MSEK. The credit facility has been issued at fair market terms by a group of existing shareholders including Crafoord and Segulah, as well DBT Capital, a part of Noba Bank Group.The credit facility of total 50 MSEK consists in part of a loan and in part of a revolving credit facility that can be called upon to cover peaks in working...

Read more

Senzime Q4 2025: Accelerated Growth and Continued Clear Path to Profitability

February 18, 2026 2:45 AM

Senzime AB's (publ.) (STO:SEZI)(OTCQX:SNZZF) year-end report for January - December 2025 is now available on the company's website www.senzime.com.Financial summary October-December 2025Net sales increased by 102 percent to MSEK 28.3 (14.0)Currency-adjusted net sales amounted to MSEK 31.5, an increase of 125 percentGross margin before depreciation amounted to 25.1 percent (67.4) affected by currency effects, US tariffs and inventory write-down...

Read more

IRLAB: Invitation to the Year-End Report 2025 Presentation and Webcast

February 18, 2026 1:15 AM

IRLAB Therapeutics AB (Nasdaq Stockholm:IRLAB A)(STO:IRLAB-A)(FRA:6IRA), a company discovering and developing novel treatments for Parkinson's disease, today announced that the company will hold a presentation in conjunction with the publication of the year-end report for 2025. The interim report will be published on Wednesday, February 25, 2026, at 07:00 CET.The presentation will be held on February 25, 2026, at 10:00 CET via digital webcast....

Read more

Pulse Radiology Education Featured in New Industry Spotlight

February 17, 2026 3:00 PM

Pulse Radiology Education, a leading provider of hybrid radiology training programs, has been featured in a new industry spotlight highlighting its founder, Neil Huber, and the company's mission to expand access to advanced ARRT-approved training for working radiologic technologists (RTs). Building on the themes of the interview, Pulse is using this moment to raise awareness about the nationwide shortage of specialized imaging professionals and...

Read more

MEDHOST Announces Strategic Partnership with RevSpring to Enhance Patient Engagement and Financial Experience Solutions 

February 17, 2026 12:00 PM

MEDHOST, a leading provider of clinical and financial healthcare technology solutions, today announced a strategic partnership with RevSpring, a leader in healthcare engagement and payment solutions. This collaboration will enable MEDHOST to offer a comprehensive suite of Pre-Care, Post-Care, and IVR solutions designed to elevate the patient experience while enhancing operational efficiency for hospitals and healthcare organizations.Through this...

Read more

Cercare Medical Releases Version 18 of Neurosuite: Advancing Stroke and Oncology Workflows

February 17, 2026 10:45 AM

Cercare Medical, a leader in advanced neuroimaging software, today announces the launch of CERCARE MEDICAL NEUROSUITE (CMN) Version 18. The new release delivers important innovations for both stroke and oncology workflows, driven directly by clinical feedback and a continued focus on automation, usability, and diagnostic confidence."Version 18 is about delivering tangible value where it matters most-speed, clarity, and confidence in clinical...

Read more

The Language Group Announces Secure and Compliant On-Demand Healthcare Translation Platform Fetch is Now Patent-Protected

February 17, 2026 9:30 AM

The Language Group (TLG), a leader in language services and technology-enabled solutions, today announced that Fetch, its on-demand healthcare translation platform, is now patent protected. Designed to address language access as a patient safety, compliance, and equity imperative, Fetch brings together people, process, and technology to simplify how clinically critical translations are requested, delivered, and embedded into real-world...

Read more